Trials / Completed
CompletedNCT02894541
Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519
A Randomized, Open-label, Single Dose, 1-sequence, 3-treatment, 3-period Crossover Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the effects of food on the pharmacokinetics/pharmacodynamics of CKD-519.
Detailed description
A randomized, open-label, single dose, 1-sequence, 3-treatment, 3-period crossover study to investigate the effects of food on the pharmacokinetics/pharmacodynamics of CKD-519 in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-519 100mg | |
| DRUG | CKD-519 200mg | |
| DRUG | CKD-519 100mg | |
| DRUG | CKD-519 200mg |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2016-11-01
- Completion
- 2017-01-01
- First posted
- 2016-09-09
- Last updated
- 2017-02-23
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02894541. Inclusion in this directory is not an endorsement.